Gilad Halpert

About

Dr. Gilad Halpert is a biologist and immunologist specializing in inflammatory and autoimmune diseases, advanced drug delivery systems, functional autoantibodies, extracellular vesicles, and precision medicine. He completed his B.Sc. in Biology and his M.Sc. and Ph.D. in Biotechnology at Bar-Ilan University, Israel, where his doctoral research focused on the therapeutic potential of tellurium-based immunomodulators for inflammatory bowel disease (IBD).
Dr. Halpert carried out postdoctoral training at the Center for Nanomedicine, Johns Hopkins University School of Medicine, USA, where he gained expertise in nanomedicine-based therapeutic delivery for IBD. He is currently research manager at the Center for Autoimmune Diseases, Sheba Medical Center, Israel, where he leads innovative studies on inflammatory, autoimmune, and rheumatic diseases, including IBD, rheumatoid arthritis, and fibromyalgia.
In addition to his research, Dr. Halpert is a Senior Lecturer and Principal Investigator at the Laboratory of Immune Cell Biology and Autoimmune Diseases Dina Recanati Faculty of Medicine, Reichman University, Israel, where he shares his expertise with future healthcare professionals.

Employment

• Sheba Medical Center Principal Investigator
• Reichman University Senior Lecturer and Principal Investigator

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications

Publications are unavailable.